Clinical Trial Update: Mesylate Apatinib for Stage Ⅳ STS After Failure of Chemotherapy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update of apatinib mesylate for adult soft tissue sarcoma after chemotherapy failure; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Soft Tissue Sarcoma

Drugs mentioned

• Apatinib Mesylate (apatinib)

Snippet

Sponsor: Tianjin Medical University Cancer Institute and Hospital | Conditions: Soft Tissue Sarcoma, Adult, Stage II | Phase 2 | Status: UNKNOWN